Bank of America’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14
Closed 7452
2017
Q3
$0 Sell
14
-86
-86% -$698 ﹤0.01% 7461
2017
Q2
$1K Sell
100
-63
-39% -$518 ﹤0.01% 6882
2017
Q1
$1K Buy
163
+162
+16,200% +$1.43K ﹤0.01% 6912
2016
Q4
$0 Sell
1
-316
-100% -$2.36K ﹤0.01% 7560
2016
Q3
$2K Buy
+317
New +$2.19K ﹤0.01% 6880
2014
Q1
Sell
-26
Closed 8321
2013
Q4
$0 Buy
+26
New +$318 ﹤0.01% 8331
2013
Q3
Sell
-4
Closed 8152
2013
Q2
$0 Buy
+4
New +$29 ﹤0.01% 7832

Other funds holding MGCD

Bank of America's MGCD Position: Q4 2017 in Review

Bank of America sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 14 shares.

Bank of America first reported a position in MGCD in Q2 2013 and held it in 7 quarters. The position peaked at $2K in Q3 2016. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

  • Bank of America reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
  • Bank of America sold 14 MGC Diagnostics Corporation shares in Q4 2017.
  • Bank of America first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 7 quarters.
  • Bank of America's MGC Diagnostics Corporation position peaked at $2K in Q3 2016.
  • 12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.